Endometrial Thickness 5 mm in a 56-Year-Old Menopausal Woman
In a postmenopausal woman with an endometrial thickness of 5 mm, endometrial tissue sampling should be performed, as this meets the threshold for evaluation of potential endometrial pathology including cancer.
Clinical Context and Risk Assessment
An endometrial thickness of 5 mm in a postmenopausal woman sits at a critical diagnostic threshold. While an endometrial thickness ≤4 mm carries a nearly 100% negative predictive value for endometrial cancer 1, a thickened endometrium (≥5 mm) generally prompts evaluation by endometrial tissue sampling 1. This 5 mm measurement represents the boundary where the risk-benefit calculation shifts toward active investigation.
Recommended Management Algorithm
If the Patient Has Postmenopausal Bleeding:
- Proceed directly to endometrial tissue sampling (endometrial biopsy via Pipelle device, which has 99.6% sensitivity for detecting endometrial carcinoma 2)
- The presence of bleeding with 5 mm thickness mandates tissue diagnosis regardless of other factors
- Hysteroscopy with biopsy can be used as a definitive diagnostic step if needed 2
If the Patient is Asymptomatic:
The evidence here shows some nuance, but errs toward intervention:
- At exactly 5 mm in an asymptomatic patient, endometrial sampling is recommended 1
- Some research suggests that asymptomatic women might be managed conservatively with higher thresholds (7-10 mm) 3, 4, 5, 6, but these are research findings, not guideline recommendations
- The ACR Appropriateness Criteria clearly state that ≥5 mm prompts tissue sampling in postmenopausal women 1
Important Clinical Considerations
Why 5 mm Matters:
The 4 mm threshold provides excellent reassurance (nearly 100% NPV for cancer), but once you reach 5 mm, you've crossed into territory where:
- Endometrial cancer cannot be reliably excluded
- Benign pathology (polyps, hyperplasia) becomes more common
- The risk-benefit ratio favors tissue diagnosis over observation
Ultrasound Characteristics to Evaluate:
Beyond just thickness, assess 1:
- Echogenicity and texture of the endometrium (abnormal patterns correlate with pathology)
- Vascularity on Doppler imaging (can help identify polyps or cancer)
- Focal versus diffuse thickening
If focal abnormalities are present, consider saline infusion sonohysterography to better characterize the lesion before proceeding to tissue sampling 1.
Common Pitfalls to Avoid
Don't rely solely on the absence of symptoms: While 96.1% of malignant endometrial pathology presents with bleeding 6, asymptomatic cancers do occur, particularly at thicknesses ≥5 mm 4, 7
Don't repeat ultrasound as the primary strategy at 5 mm: While repeat imaging can be done if initial sampling is negative 1, the first step at ≥5 mm should be tissue diagnosis, not surveillance
Don't confuse premenopausal and postmenopausal thresholds: The 5 mm cutoff is specific to postmenopausal women; premenopausal women have no validated thickness cutoff 1
Tissue Sampling Options (in order of preference):
- Pipelle or Vabra endometrial biopsy (office-based, 99.6% and 97.1% sensitivity respectively) 2
- Hysteroscopy with directed biopsy if office sampling is inadequate or if focal lesions need characterization 2
- Dilation and curettage is less preferred due to false-negative rates up to 10% 2
Risk Factors That Lower Your Threshold for Intervention:
Even at exactly 5 mm, be more aggressive with tissue sampling if the patient has:
- Obesity (BMI >30)
- History of unopposed estrogen exposure
- Tamoxifen use
- Diabetes or hypertension
- Lynch syndrome family history 2
The bottom line: At 5 mm in a postmenopausal woman, the guideline-based recommendation is clear—proceed to endometrial tissue sampling to exclude malignancy and significant premalignant pathology 1.